Results 61 to 70 of about 28,857 (204)

Exposure to Systemic Antimicrobials During Pregnancy and Risk of Miscarriage: A Population‐Based Registry Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 7, Page 1394-1404, June 2026.
ABSTRACT Objective To estimate miscarriage risk following gestational antimicrobial exposure while addressing biases that have affected previous studies. Design Population‐based cohort study. Setting Linkage of four nationwide registries: Medical Birth Registry of Norway (MBRN), Norwegian Prescribed Drug Registry (NorPD), Norwegian Patient Registry ...
Thomas Boissiere‐O'Neill   +3 more
wiley   +1 more source

Overview of Vulvovaginal Candidiasis Diagnosis and Treatment

open access: yes, 2022
Vaginal yeast infections, also called yeast vaginitis or vulvovaginal candidiasis (VVC), are the second most common cause of vaginitis and account for more than ten million medical visits annually.
Rodriguez, Diana P
core   +1 more source

Use of natamycin and ketoconazole suppositories in the treatment of recurrent vulvovaginal candidiasis [PDF]

open access: yesРМЖ. Мать и дитя, 2018
Use of natamycin and ketoconazole suppositories in the treatment  of recurrent vulvovaginal candidiasis I.I. Ivanova1, Yu.E. Dobrokhotova2 1 Pirogov Russian National Research Medical University, Moscow, Russian Federation 2 Clinical ...
I.I. Ivanova, Yu.E. Dobrokhotova
doaj  

Probiotic supplementation during pregnancy for vaginal microbiota improvement and pathogen clearance: A systematic review and meta‐analysis

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 999-1016, June 2026.
Probiotic supplementation during pregnancy shows a modest, non‐robust increase in Group B Streptococcus decolonization, with no consistent benefit for bacterial vaginosis or vulvovaginal candidiasis. Probiotics may serve as a non‐antibiotic adjunct, but standardized regimens and ecological diagnostic frameworks are required.
Zimo Liu   +3 more
wiley   +1 more source

Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 1019-1029, June 2026.
In Chinese patients with moderate to severe plaque psoriasis, bimekizumab treatment was well tolerated and led to significantly higher clinical response rates versus placebo, including complete skin clearance. These findings were consistent with global studies and suggest that bimekizumab is an effective treatment option for Chinese people living with ...
Lin Cai   +11 more
wiley   +1 more source

Probiotic‐based strategies in vulvovaginal candidiasis management: A comprehensive review of mechanisms and future directions

open access: yesInterdisciplinary Medicine, Volume 4, Issue 3, May 2026.
This review focuses on vulvovaginal candidiasis (VVC), examining its epidemiology, the pathogenesis of Candida albicans, and its relationships with vaginal microbiota. It comprehensively reviews probiotic‐based management strategies and their mechanisms of action, and concludes by discussing current limitations, challenges and future research ...
Tong Chen   +13 more
wiley   +1 more source

Vulvovaginal candidiasis [PDF]

open access: yesInternational Journal of Gynecology & Obstetrics, 2006
D, Moreira, C R, Paula
openaire   +4 more sources

Safety and Efficacy of a 24‐Cycle Administration of a Drospirenone‐Only Pill in Japanese Women

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 52, Issue 5, May 2026.
ABSTRACT Aim We conducted a 24‐cycle study to evaluate long‐term safety of 4 mg of drospirenone (DRSP), a progestin‐only pill (POP), for contraception in Japanese women. Methods A multicenter, single‐arm 24‐cycle study was conducted in women who participated in the 13 cycle study of DRSP.
Kunio Kitamura   +5 more
wiley   +1 more source

Clotrimazole‐loaded PLGA microparticles for local drug delivery to the vagina: Shape does matter

open access: yesAnimal Models and Experimental Medicine, Volume 9, Issue 4, Page 752-764, April 2026.
Clotrimazole‐loaded PLGA microparticles for intravaginal delivery. Abstract Background Intravaginal drug administration is the most promising strategy for treating vaginal infections to protect women's health, such as vulvovaginal candidiasis (VVC). However, conventional vaginal formulations in the clinic face challenges such as drug leakage and low ...
Yanyu Li   +8 more
wiley   +1 more source

Demographic features, underlying conditions, and pre-diagnosis medications among patients with vulvovaginal candidiasis, recurrent vulvovaginal candidiasis, and females with an outpatient gynecologic visit.

open access: yes, 2022
Demographic features, underlying conditions, and pre-diagnosis medications among patients with vulvovaginal candidiasis, recurrent vulvovaginal candidiasis, and females with an outpatient gynecologic visit.
Brendan R. Jackson (8575074)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy